2.17
6.37%
0.13
Vorhandelsmarkt:
2.26
0.09
+4.15%
Schlusskurs vom Vortag:
$2.04
Offen:
$2.05
24-Stunden-Volumen:
4.51M
Relative Volume:
1.61
Marktkapitalisierung:
$60.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-10.58M
KGV:
-1.8083
EPS:
-1.2
Netto-Cashflow:
$-9.21M
1W Leistung:
+17.30%
1M Leistung:
-23.59%
6M Leistung:
+126.47%
1J Leistung:
+80.83%
Microbot Medical Inc Stock (MBOT) Company Profile
Firmenname
Microbot Medical Inc
Sektor
Telefon
908-938-5561
Adresse
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Vergleichen Sie MBOT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
MBOT
Microbot Medical Inc
|
2.17 | 60.83M | 0 | -10.58M | -9.21M | -1.20 |
ISRG
Intuitive Surgical Inc
|
588.50 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
BDX
Becton Dickinson Co
|
227.21 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
ALC
Alcon Inc
|
91.65 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
RMD
Resmed Inc
|
237.18 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
WST
West Pharmaceutical Services Inc
|
330.47 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2020-01-13 | Bestätigt | H.C. Wainwright | Buy |
2019-12-24 | Bestätigt | H.C. Wainwright | Buy |
2018-01-31 | Eingeleitet | Ladenburg Thalmann | Buy |
Microbot Medical Inc Aktie (MBOT) Neueste Nachrichten
Microbot Medical (NASDAQ: MBOT) Announces Acceptance of Late-Breaking Abstract for SIR Annual MeetingOn February 4, 2025, Microbot Medical Inc., a developer of the LIBERTY® Endovascular Robotic System, disclosed the acceptance of a late-breakin - Defense World
Microbot Medical regains Nasdaq compliance with bid price - MSN
Microbot Medical Files Prospectus Relates To Resale From Time To Time Of Up To 15.97 Million Shares By Selling Stockholders - Marketscreener.com
Microbot Medical Presents LIBERTY System at Radiology Event - TipRanks
Microbot Medical® Announces Late-Breaking Abstract - GlobeNewswire
Microbot Medical to Present Groundbreaking LIBERTY Robot Trial Data at SIR 2025 | MBOT Stock News - StockTitan
Why Microbot Medical Inc. (MBOT) Is Skyrocketing So Far In 2025 - Insider Monkey
H.C. Wainwright analysts reiterates a Buy rating for Microbot Medical Inc (MBOT) - Knox Daily
Microbot Medical regains Nasdaq compliance with bid price By Investing.com - Investing.com Australia
Microbot Medical approves special CEO bonus - MSN
HC Wainwright Forecasts Strong Price Appreciation for Microbot Medical (NASDAQ:MBOT) Stock - Defense World
Microbot Medical stock target raised to $9 by H.C. Wainwright - MSN
Microbot Medical Authorizes Special Bonus for CEO - Defense World
Microbot Medical approves special CEO bonus By Investing.com - Investing.com South Africa
Day Trading Grandpa Loses Microbot Short Swing Harm Appeal (1) - Bloomberg Law
Microbot Medical (NASDAQ: MBOT) Appoints Director of Operations to Strengthen Production Efficiencies - Defense World
Microbot Medical Strengthens Its Management Team - citybiz
Microbot Medical Appoints New Director of Operations - TipRanks
Microbot Medical® Strengthens Its Management Team in Support of the Anticipated Commercial Launch of LIBERTY® - GlobeNewswire
Microbot Medical Strengthens Leadership Team Ahead of LIBERTY Robot Launch in 2025 - StockTitan
Microbot Medical Inc. (NASDAQ:MBOT) Short Interest Update - Defense World
Microbot Medical Appoints David J. Wilson to the Board of Directors - citybiz
Microbot Medical® Strengthens Its Commercial Capabilities with the Addition of David J. Wilson to the Board of Directors - The Manila Times
Microbot Medical Names Former J&J Cordis President David Wilson to Board Ahead of LIBERTY Launch - StockTitan
Microbot Medical (NASDAQ: MBOT) Announces $8.6 Million Registered Direct Offering - Defense World
Contrasting Microbot Medical (NASDAQ:MBOT) and CVR Medical (OTCMKTS:CRRVF) - Defense World
Microbot Medical Closes $8.6 Million Registered Direct Offering - citybiz
Microbot Medical closes $8.6M registered direct offering - TipRanks
Microbot Medical Secures $8.6M Funding to Advance LIBERTY® Robotic System Development - StockTitan
Microbot Medical (NASDAQ: MBOT) Enters into ATM Agreement; Provides Intellectual Property UpdateMicrobot Medical Inc. recently disclosed the details of the At-the-Market Offering Agreement (ATM Agreement) entered into with H.C. Wainwright & Co. LLC. - Defense World
Microbot Medical prices 3.79M shares at $2.27 in registered direct offering - Yahoo Finance
Microbot Medical Announces $7 Million Registered Direct Offering - Defense World
Microbot Medical announces $8.6M registered direct offering - MSN
Microbot Medical Raises $8.6M in Direct Offering to Advance LIBERTY® Robotic System Development - StockTitan
Microbot Medical Stock Slides From 52-Week High - MarketWatch
Microbot Medical Raises a Total of Approximately $11.8 - GlobeNewswire
Microbot Medical Secures $11.8M Funding to Advance LIBERTY® Robotic System Development - StockTitan
Form 424B5 Microbot Medical Inc. - StreetInsider.com
SEC Form 424B5 filed by Microbot Medical Inc. - Quantisnow
Microbot Medical concludes at-the-market offering By Investing.com - Investing.com Australia
MBOT stock touches 52-week high at $2.76 amid market optimism - Investing.com Nigeria
Microbot Medical announces $7M offering to support surgical robot commercialization - Mass Device
Microbot Medical Trades at 52-Week High After Direct Offering - MarketWatch
Microbot Medical concludes at-the-market offering - Investing.com India
Microbot (MBOT) Capture Pre-Market Surge With An Equity Move - Stocks Telegraph
Microbot Medical Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - GlobeNewswire
Microbot Medical Raises $7M Through Direct Offering to Advance LIBERTY® Robotic System - StockTitan
US Stocks To Open Higher In Yet Another Truncated Week: Nvidia, Robotic Stocks In Focus Ahead Of CES 2025 - Benzinga
Another Robotics Stock on the Move; Microbot Medical Inc. (Nasdaq: MBOT) - Investorideas.com newswire
Finanzdaten der Microbot Medical Inc-Aktie (MBOT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):